{
Novartis International AG

Companies

}
001122334455554433221100
001122334455554433221100

high potency active pharmaceutical ingredients market trends and future growth prospects

The High Potency Active Pharmaceutical Ingredients Market is experiencing significant growth, driven by increased demand, technological advancements, and a broadening customer base. A comprehensive report provides insights into market trends, competitive landscape, and future opportunities, highlighting key players such as Lonza and Novartis. The analysis covers various segments, production technologies, and applications, offering a detailed outlook on the industry's trajectory through 2032.
openPR.com
Merck & Co., Inc. Roche Diagnostics AG Eli Lilly and Company Teva Pharmaceutical Industries Ltd BASF AG Novartis International AG Lonza Group AG Bristol-Myers Squibb Co Cambrex Corporation Seqens Pfizer Inc. Sanofi Aventis SA Bayer AG CARBOGEN AMCIS AG Alice Mutum Viju Shah Show more
Business & Industry, Market Report
10:02 26.03.2025

eli lilly acquires scorpion therapeutics for 2.5 billion in breast cancer push

Eli Lilly has announced a $2.5 billion acquisition of Scorpion Therapeutics’ PI3Kα pipeline, aiming to compete in the breast cancer market against Novartis and Roche. The deal includes the promising candidate STX-478, which has shown a 23% response rate in patients and is designed to selectively target mutant PI3Kα, potentially avoiding adverse effects seen with existing treatments. Lilly will also create a new company for Scorpion's non-PI3Kα assets, retaining Scorpion's staff.
Fierce Biotech
Novartis International AG Roche Holding AG Eli Lilly and Company Relay Therapeutics, Inc. USA Daniel M. Skovronsky Show more
Healthcare, Market Report
15:55 13.01.2025

semaglutides market projected to reach 36.87 billion by 2028

The semaglutides market is projected to grow from $20.54 billion in 2023 to $36.87 billion by 2028, driven by rising diabetes prevalence and increased demand for effective treatments. Key players are innovating with GLP-1 receptor analogues and oral formulations to enhance patient adherence and reduce side effects. North America leads the market, while Asia-Pacific is expected to be the fastest-growing region.
GlobeNewswire News Room
United States Dollar Adocia SA Sanofi SA Eli Lilly and Company Roche Holding AG Pfizer Inc. Merck & Co., Inc. Dr. Reddy's Laboratories Limited Boehringer Ingelheim International GmbH Glaxosmithkline plc Takeda Pharmaceutical Company Limited AbbVie Inc. Novartis International AG Bristol-Myers Squibb Company Novo Nordisk A/S Cipla Limited Biocon Limited Teva Pharmaceutical Industries Ltd AstraZeneca PLC Amgen Inc. ITA IND FRA IDN CAN ESP BRA USA RUS CHN DEU AUS JPN GBR KOR Show more
Healthcare, Market Report
10:12 06.01.2025

consumer healthcare market poised for rapid growth driven by digital innovations

The consumer healthcare market is projected to grow significantly, reaching $1,476.45 billion by 2028, with a CAGR of 22.1%. Key drivers include an aging population, increased reliance on OTC medications, and the rise of e-commerce. Major players like Johnson & Johnson and Sanofi are adapting to trends in digital health and personalized care solutions.
EIN News
United States Dollar Perrigo Company plc Cardinal Health, Inc. Johnson & Johnson Church & Dwight Co., Inc. Herbalife Nutrition Ltd. Nestlé S.A. Abbott Laboratories Teva Pharmaceutical Industries Ltd. AstraZeneca PLC DSM Nutritional Products AG Pfizer Inc. Colgate-Palmolive Company AbbVie Inc. Bayer AG BASF SE Glaxosmithkline plc Novartis International AG CVS Health Corporation Boehringer Ingelheim International GmbH Sanofi Amway Corporation Novo Nordisk A/S Ipsen S.A. Bristol-Myers Squibb Company McKesson Corporation Merck & Co., Inc. The Clorox Company Reckitt Benckiser Group plc Cigna Corporation Eli Lilly and Company Brian Johnson Show more
Healthcare, Market Report
00:30 27.11.2024

global consumer health market projected to reach over 713 billion by 2033

The global consumer healthcare market is segmented by product types, including OTC pharmaceuticals, personal care products, and dietary supplements, with offline distribution channels expected to dominate. North America is projected to lead the market due to rising awareness of wellness products, while Asia Pacific is anticipated to grow rapidly, driven by increasing disposable incomes and a large elderly population. Key players include Johnson & Johnson, Procter and Gamble, and Pfizer, among others, with ongoing developments enhancing market dynamics.
Spherical Insights
United States Dollar Johnson & Johnson Colgate-Palmolive Company Bayer AG Merck & Co., Inc. Boehringer Ingelheim GmbH Nestlé S.A. Mylan N.V. Reckitt Benckiser Group plc Novartis International AG Glaxosmithkline plc Eli Lilly and Company Perrigo Company plc Sanofi Teva Pharmaceutical Industries Ltd. Abbott Laboratories Pfizer Inc. Procter and Gamble ESP IND QAT GBR JPN KOR AUS ARE CHN DEU USA BRA RUS MEX CAN ARG ITA SAU ZAF Brian Johnson Mylan Nv Show more
Healthcare, Market Report
18:35 18.11.2024

nanotechnology revolutionizes cancer treatment with targeted drug delivery systems

Nanotechnology-based drug delivery systems are revolutionizing cancer treatment by enabling targeted drug delivery to tumors while minimizing harm to healthy tissues. The market is expected to grow rapidly, particularly in hospitals and clinics, driven by significant investments and advancements in North America and Asia-Pacific. Key players include major pharmaceutical companies, with ongoing innovations enhancing treatment efficacy and patient outcomes.
Spherical Insights
United States Dollar Celgene Company AstraZeneca PLC Amgen Inc. Johnson and Johnson Merck KGaA Pfizer Ltd Novartis International AG Bristol-Myers Squibb Company Teva Pharmaceutical Industries Limited CHN FRA ESP BRA KOR IND ZAF ITA SAU ARG CAN USA RUS JPN MEX GBR DEU ARE AUS QAT Nanobiotix SA Bristol-Myers Squibb Company Teva Pharmaceutical Industries Limited Johnson and Johnson Merck KGaA Show more
Healthcare, Market Report
22:36 06.11.2024
Trending
Subcategory
Startups & Entrepreneurship Corporate News Industry Trends Retail and Consumer Goods Supply Chain Management Global Trade Developments Stock Market Updates Industry Mergers & Acquisitions AI Applications Private Equity Deals Funding Rounds & Investments AI Innovations Fintech Startups Energy Sector Developments Government Economic Policies Emerging Startups Global Financial Events CEO Changes Central Bank Actions Commodities
Countries:
USA CHN IND JPN SAU ARE GBR SGP VNM KOR AUS MYS CAN IDN HKG DEU BGD QAT THA EGY
Companies:
Apple Inc. Google Inc. Tesmec S.p.A. Tesla, Inc. Amazon.com, Inc. OpenAI ERC USD Walmart Inc. Microsoft Corporation Foxconn Technology Co., Ltd. Hollywood Bowl Group PLC NASDAQ Composite Wise plc Mastercard Inc Alphabet Inc. SWIGGY LIMITED Mistral 1 NVIDIA Corporation Nippon Steel Corp CCTV 50 CSR Medtronic plc
Currencies:
United States Dollar Indian Rupee Chinese Yuan Euro British Pound Sterling Japanese Yen United Arab Emirates Dirham Vietnamese Đồng New Zealand Dollar Thai Baht Australian Dollar Indonesian Rupiah Singapore Dollar Saudi Riyal Omani Rial Bahraini Dinar Qatari Riyal Algerian Dinar Egyptian Pound
People:
Donald Trump Asmaa Naga Basma Bushnak Maha Taibah Elon Musk Hossam Ahmed Tasneem Islam Joe Biden Sri Mulyani Mark Carney Howard Lutnick Yongqiang He Ursula von der Leyen Xi Jinping Aman Gupta Scott Bessent Afeef Zaman Hareb Rashed Rajneel Kumar Ahmed al-Sharaa

Machinary offers a groundbreaking, modular, and customizable solution that provides advanced financial news and statistical analysis. Our platform goes beyond traditional quantitative analysis, offering users a comprehensive understanding of real-time market dynamics, event detection, and risk analysis.

Links

Address

Newsletter

© 2025 by Machinary.com - Version: 1.0.0.0. All rights reserved

Layout

Color mode

Theme mode

Layout settings

Save settings
Reset settings
Seems like the connection with the server has been lost. It can be due to poor or broken network. Please hang on while we're trying to reconnect...
Oh snap! Failed to reconnect with the server. This is typically caused by a longer network outage, or if the server has been taken down. You can try to reconnect, but if that does not work, you need to reload the page.
Oh man! The server rejected the attempt to reconnect. The only option now is to reload the page, but be prepared that it won't work, since this is typically caused by a failure on the server.